Rctd-031 Updated Jun 2026

| Model | Dosing | Key Outcome | |-------|--------|-------------| | Bleomycin‑induced lung fibrosis (mouse) | 10 mg/kg PO daily | 55 % reduction in hydroxyproline content; improved lung compliance | | hATTR transgenic mouse | 5 mg/kg PO BID | ↓ serum TTR aggregates by 42 %; histology showed reduced myocardial fibrosis | | Human fibroblast culture (IPF patient‑derived) | 0.1‑1 µM | ↓ COL1A1 & α‑SMA mRNA by >60 % without affecting cell viability |

| Feature | How to Enable | Typical Use Cases | |---------|---------------|-------------------| | | Menu → Advanced → PID → Auto‑Tune (or manual entry) | Precise control for processes with high thermal inertia. | | Multi‑Probe Support (if firmware ≥ 2.5) | Plug additional probes into “TEMP IN‑2”, “TEMP IN‑3” ports. | Monitoring separate zones (e.g., incubator + storage). | | Scheduled Set‑Points | App → Scheduler → Add “Morning 20 °C”, “Night 15 °C” | Energy‑saving or diurnal experiments. | | Remote Alarm Push | App → Settings → Notifications → Enable “Push” | Instant alerts on phone/email when temperature exceeds limits. | | Firmware Update | App → Device → Firmware → “Check for update” | Improves stability, adds new features, patches security. | rctd-031

| Generation | Net cooling power (W m⁻²) | ΔT (°C) | Power density (mW cm⁻²) | Lifetime (h) | |------------|--------------------------|--------|--------------------------|--------------| | RCTD‑001 – RCTD‑010 | 45–60 | 2–4 | 1.5–2.0 | 2 000 | | RCTD‑011 – RCTD‑020 | 65–80 | 4–6 | 3.2–4.0 | 5 000 | | | 105 | 7.5 | 6.2 | >10 000 | | Model | Dosing | Key Outcome |